Pharmaceutical Composition for the Treatment of Kidney Disease
We invented and developed a safe and highly effective pharmaceutical composition for the treatment of kidney diseases. The composition is compounded in our affiliated Yikang hospital and was approved for the treatment of kidney disease in 1996 by the local healthcare authority.
In the last 20 years, we have treated thousands of kidney patients successfully. The composition has shown excellent efficacy against nephrotic syndrome (including pediatric nephrotic syndrome), IgA nephropathy, glomerulonephritis, and diabetic nephropathy (please see our preliminary statistics and exemplary patient profiles). It has also shown very positive effect on certain kidney failure patients. Many patients fully recovered. Some patients were able to stop kidney failure and avoid dialysis. We are performing research to understand why the composition has such a high success rate.
Tianjin Renji Hospital was launched to serve international kidney patients. Click here to see some common questions about the treatment.